SNGX News and Press, Soligenix Inc. From 02/11/20

PRINCETON, N.J. , Feb. 11, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that ...

Soligenix is a small biotech company that will announce results from two separate PH 3 clinical trials: FLASH study SGX301 in patients with cutaneous T cell lymphoma (CTCL) will be announced in 2 months, and top-line results of DOM-INNATE study of SGX942 for the treatment of oral mucositis...

Are These Penny Stocks On Your Watch List Right Now? Generally speaking, most new investors do not often have a big budget at the start of their investing journey. Now, this isn’t always the case and “budget” is subjective to who you speak to. Some people may consider $1,0...

PRINCETON, N.J. , Feb. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Japanes...

Miami Beach, Florida--(Newsfile Corp. - January 30, 2020) - Soligenix (NASDAQ: SNGX) stock continued its price surge with gains exceeding 95% since the first of the year*. Investors are eyeing the near-term release of topline data for its late-stage drug candidate, SGX301, targeting the treatm...

PRINCETON, N.J. , Jan. 30, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its P...

Are These Companies On Your Penny Stocks Watch List Right Now? It is a well-known fact that investors are always on the lookout for promising penny stocks. The simple reason behind that is the fact that these stocks can generate enormous returns. Over the years, many investors have made money ...

January 22, 2020 Palm Beach, FL –January 22, 2020 – Pancreatic cancer is a notoriously aggressive and hard-to-treat malignancy; the five-year survival rate is less than 10%. Treatment options for pancreatic cancer are limited to surgery, radiation, and chemotherapies; th...

Miami Beach, Florida--(Newsfile Corp. - January 16, 2020) - Soligenix (NASDAQ: SNGX), a late-stage pharmaceutical company working to improve the current standard of care for numerous rare diseases through the development and commercialization of novel treatments, is nearing the release of topl...

PRINCETON, N.J. , Jan. 14, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update let...